Health
Why AstraZeneca Shares Slumped This Week Despite Positive Vaccine News – Motley Fool
Despite positive news this week regarding its COVID-19 vaccine, AstraZeneca shares dropped due to concerns about side effects and market competitiveness.
The news Monday regarding AstraZeneca(NYSE:AZN)’s trial of coronavirus vaccine AZD1222 seemed to be the type of information that would push a stock’s price up, not down.
Interim results from the phase 1/2 trial of the company’s vaccine, which was developed in partnership with Oxford University, suggested that it drove antibody and T-cell immune responses against COVID-19 in each of the study’s 1,077 participants.
While the trial is only into its third month, that’s a big deal. No COVID-19 vacc…
Continue Reading